Department of Physiological Sciences

Permanent URI for this community

https://scholar.sun.ac.za/handle/10019.1/232

Browse

Browsing Department of Physiological Sciences by Subject "Adipose tissue"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Chemoresistance : intricate interplay between breast tumor cells and adipocytes in the tumor microenvironment
    (Frontiers Media, 2018-12-11) Mentoor, Ilze; Engelbrecht, Anna-Mart; Van Jaarsveld, Paul J.; Nell, Theo A.; Vella, Veronica
    Excess adipose tissue is a hallmark of an overweight and/or obese state as well as a primary risk factor for breast cancer development and progression. In an overweight/obese state adipose tissue becomes dysfunctional due to rapid hypertrophy, hyperplasia, and immune cell infiltration which is associated with sustained low-grade inflammation originating from dysfunctional adipokine synthesis. Evidence also supports the role of excess adipose tissue (overweight/obesity) as a casual factor for the development of chemotherapeutic drug resistance. Obesity-mediated effects/modifications may contribute to chemotherapeutic drug resistance by altering drug pharmacokinetics, inducing chronic inflammation, as well as altering tumor-associated adipocyte adipokine secretion. Adipocytes in the breast tumor microenvironment enhance breast tumor cell survival and decrease the efficacy of chemotherapeutic agents, resulting in chemotherapeutic resistance. A well-know chemotherapeutic agent, doxorubicin, has shown to negatively impact adipose tissue homeostasis, affecting adipose tissue/adipocyte functionality and storage. Here, it is implied that doxorubicin disrupts adipose tissue homeostasis affecting the functionality of adipose tissue/adipocytes. Although evidence on the effects of doxorubicin on adipose tissue/adipocytes under obesogenic conditions are lacking, this narrative review explores the potential role of obesity in breast cancer progression and treatment resistance with inflammation as an underlying mechanism.